ATTR Amyloidosis Behandlungsmarkt GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

ATTR Amyloidosis Behandlungsmarkt wird nach Typ segmentiert (Hereditary ATTR Amyloidosis, Wildtyp ATTR Amyloidosis), Durch Behandlung (Pharmacological Therapies, Organtransplantation, Supportive Care), By Route of Administration(Oral, Intravenous, Subcutaneous), By End User (Hospitals, Specialty Clinics, Homecare Settings), By Geography America, Middle America, USA, USA, USA, USA, USA, USA Der Bericht bietet den Wert (in Mrd. USD) für die oben genannten Segmente.

ATTR Amyloidosis Behandlungsmarkt Leaders

  • Pfizer Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharma, Inc.
  • Eidos Therapeutics, Inc.
  • Akcea Therapeutics, Inc.
*Disclaimer: Major players are listed in no particular order.

ATTR Amyloidosis Behandlungsmarkt - Company List

  • Pfizer Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharma, Inc.
  • Eidos Therapeutics, Inc.
  • Akcea Therapeutics, Inc.
  • Prothena Corporation plc
  • Corino Therapeutics, Inc.
  • AstraZeneca pl